Luxcel Biosciensces Ltd.
- Company typePublic
- Founded2002
- HeadquartersCork, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Luxcel Biosciensces Ltd. firmographics
Firmographics- Name
- Luxcel Biosciensces Ltd.
- Legal name
- Luxcel Biosciensces Ltd.
- Website
- https://luxcel.com
- Company type
- Public
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Luxcel Biosciensces Ltd. industry classification
Industry- Product category
- Cell Analysis Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where Luxcel Biosciensces Ltd. is headquartered
LocationHeadquarters
- HQ city
- Cork
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Luxcel Biosciensces Ltd. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- XF Analyzers: Sale of Seahorse XF analyzer instruments - capital equipment providing metabolic data on energy production in live cells in real time. Includes XF Pro analyzer with enhanced precision and pharma-oriented workflows.
- XF Sensor Cartridges & Cell Culture Microplates: Recurring consumable revenue from proprietary sensor cartridges and specialized cell culture plates specific to application and cell type needs.
- XF Assay Kits, Reagents & Cell Assay Media: Recurring consumable revenue from turnkey assay kits, reagents, and tested media for Seahorse XF workflows.
- XF Software Licenses & Support: Software for assay design, data acquisition, analysis, and reporting with software upgrades and support services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based enterprise pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Luxcel Biosciensces Ltd. product offering
Product offeringCore offering
Luxcel Biosciensces Ltd. is associated with the Seahorse XF real-time cell metabolic analysis platform, which provides noninvasive, real-time measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells via proprietary optical sensor cartridges and cell culture microplates. The offering spans XF analyzers (including the XF Pro), proprietary sensor cartridges and plates, turnkey assay kits/reagents/media, and XF software for assay design, data acquisition, and analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Seahorse XF Analyzers (including XF Pro) Capital equipment instrument that measures oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells in real time, providing metabolic data on energy production. The XF Pro model adds enhanced precision and pharma-oriented workflows. For pharmaceutical, biopharma, and life science research customers.
- XF Sensor Cartridges & Cell Culture Microplates Proprietary, application- and cell-type-specific consumables used with Seahorse XF analyzers to perform real-time metabolic measurements. Recurring consumable revenue stream. For pharmaceutical, biopharma, and research institution customers.
- XF Assay Kits, Reagents & Cell Assay Media Ready-to-use, validated assay kits, reagents, and cell assay media that provide turnkey workflows for Seahorse XF metabolic assays. Recurring consumable revenue stream. For researchers using the Seahorse XF platform.
- XF Software Platform Software used to design XF assays, acquire data from the analyzer, and analyze and report cellular bioenergetics results. Includes upgrade and support services. For users of the Seahorse XF platform.
Quantifiable outcome
- Seahorse XF Pro analyzer won 2023 Scientists' Choice Awards as best new drug discovery & development product of 2022
Companies that use Luxcel Biosciensces Ltd.
Customer profileSegments4 records
Ideal customer profiles4 records
Luxcel Biosciensces Ltd. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Luxcel Biosciensces Ltd. partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights5 records
Luxcel Biosciensces Ltd. competitors and assessment
Company assessmentEmerging players
- Bruker: Analytical instruments specialist whose cell-analysis and molecular spectroscopy tools increasingly intersect with metabolic profiling workflows. Relevant as an emerging competitor in adjacent analytical categories.
Broad incumbents
- Agilent Technologies: Parent/incumbent that now commercializes the Seahorse XF / Luxcel-origin technology within its broader life-science instruments portfolio (mass spec, chromatography, cell analysis). Directly comparable as the operating channel for Luxcel's IP and the dominant commercial vehicle.
- PerkinElmer: Life-science diagnostics and analytical instrument provider with overlapping cell-analysis, imaging, and lab-services capabilities serving pharma/biopharma research accounts.
- Danaher (Beckman Coulter Life Sciences / Cytiva): Diversified life-sciences conglomerate with flow cytometry, cell analysis, and bioprocessing franchises that compete in adjacent instrument categories serving the same pharma/biopharma research customers.
- Thermo Fisher Scientific: Global life-science tools incumbent offering competing cell-analysis instruments, lab consumables, and pharma R&D workflows. Comparable because it sells overlapping capital equipment and consumables into the same pharmaceutical/biopharma customer base.
- Merck KGaA (Life Science / Sigma-Aldrich): Broad life-science tools incumbent offering cell-culture media, reagents, and analytical instruments. Comparable due to overlapping consumables footprint and shared pharma/biopharma research customer base.
Direct peers
- Promega: Private life-science tools company supplying cell-based assay reagents, kits, and instruments. Comparable because its assay kits/reagents compete in similar pharma/biopharma cell-analysis workflows.
- Sartorius: Direct peer in cell analysis and bioprocessing instrumentation serving pharma/biopharma with live-cell analysis and consumables. Closely aligned business model combining capital equipment with recurring consumables and overlapping drug-discovery workflows.
- Bio-Techne: Developer of life-science research reagents, assay kits, and analytical instruments including cell-based assay workflows. Comparable due to overlapping assay kits/reagents revenue model and shared pharma/biopharma research customer base.
Others
- Lonza: Global CDMO with cell-and-gene therapy manufacturing services. Comparable as a customer/channel partner for cell metabolism and potency assays used in therapeutic manufacturing QC.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Luxcel Biosciensces Ltd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Luxcel Biosciensces Ltd. leadership team
Management profileNumber of profiles
Luxcel Biosciensces Ltd. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Luxcel Biosciensces Ltd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Luxcel Biosciensces Ltd.
What does Luxcel Biosciensces Ltd. do?
Luxcel Biosciensces Ltd. is associated with the Seahorse XF real-time cell metabolic analysis platform, which provides noninvasive, real-time measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in live cells via proprietary optical sensor cartridges and cell culture microplates. The offering spans XF analyzers (including the XF Pro), proprietary sensor cartridges and plates, turnkey assay kits/reagents/media, and XF software for assay design, data acquisition, and analysis.
Is Luxcel Biosciensces Ltd. a public or private company?
Luxcel Biosciensces Ltd. is a public company. It is classified as unknown and is currently operating.
When was Luxcel Biosciensces Ltd. founded?
Luxcel Biosciensces Ltd. was founded in 2002. It employs 11 to 50 people.
Where is Luxcel Biosciensces Ltd. based?
Luxcel Biosciensces Ltd. is headquartered in Cork, Ireland, in the Europe region.
How does Luxcel Biosciensces Ltd. make money?
Four revenue lines are on record. XF Analyzers are the primary driver. The others are XF Sensor Cartridges & Cell Culture Microplates, XF Assay Kits, Reagents & Cell Assay Media and XF Software Licenses & Support.
Who are Luxcel Biosciensces Ltd.'s main competitors?
Bruker is listed as an emerging player. Broad incumbents are Agilent Technologies, PerkinElmer, Danaher (Beckman Coulter Life Sciences / Cytiva), Thermo Fisher Scientific and Merck KGaA (Life Science / Sigma-Aldrich). Direct peers are Promega, Sartorius and Bio-Techne. Lonza is listed as an others.
Does Luxcel Biosciensces Ltd. have an API?
No public API is recorded for Luxcel Biosciensces Ltd..
What industry is Luxcel Biosciensces Ltd. in?
Luxcel Biosciensces Ltd.'s product category is Cell Analysis Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 334516 and its SIC code is 3826.